Skip to main content
OpenTrials
Completed

NCT Number: NCT02015624

EYESHOT (EmploYEd Antithrombotic Therapies in Patients With Acute Coronary Syndromes HOspitalized in iTalian Coronary Care Units)

This register will evaluate the use of different antithrombotic therapies, combinations of different drugs routinely used during any stage of hospital admission, with their timing, dosage and mode of administration, in patients with a diagnosis of Acute Coronary Syndrome in the Italian Coronary Care Unit during a study period of three weeks

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Acute Coronary Syndromes Acute Coronary Syndrome Cardiovascular Diseases Heart Diseases Myocardial Ischemia Vascular Diseases

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Ospedale San Giovanni Di Dio, S.C. Cardiologia, Agrigento, AG, Italy

Loading trial locations.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • All consecutive patients discharged with a diagnosis of Acute Coronary Syndrome ( Non ST elevation or ST Elevation) undergoing myocardial revascularization or conservative treatment , admitted to the Coronary Care Unit during the observation period established.
  • Age ≥ 18 years
  • Signed informed consent

Exclusion criteria

  • Patients enrolled in clinical trials of intervention
  • Diagnosis of Acute Coronary Syndrome caused by confounding comorbidities (eg . Trauma or surgery after non- cardiac )
  • Patients already enrolled in eyeshot from another center.

Treatment and study plan

Primary outcomes

  1. Antithrombotic drugs in patient undergoing percutaneous transluminal coronary angiography, coronary artery bypass graft or no coronary revascularization

    Time frame: Participants will be followed for the duration of hospital stay, an expected average period of 7 days

Secondary outcomes

  1. In-hospital ischemic and hemorrhagic events

    Time frame: Participants will be followed for the duration of hospital stay, an expected average period of 7 days

Sponsors and collaborators

Lead sponsor

Heart Care Foundation

Other

Collaborators

  • AstraZeneca
  • Centro Servizi ANMCO S.r.l.

Registry information

Official study title

EmploYEd Antithrombotic Therapies in Patients With Acute Coronary Syndromes HOspitalized in iTalian CCUs Registry

Acronym: EYESHOT

Important dates

Study start
2013
Primary completion
2014
Study completion
2014
First posted
Dec 19, 2013
Registry last updated
Feb 3, 2021

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.